Net Income

January data shows stable job and wage growth for U.S. small businesses, yet persistent labor shortages and rising healthcare costs paint a complex picture.

BlackSky's new deal validates its high-tech satellite intel, proving its model for turning trials into major contracts in the competitive space-tech market.

Planet DDS's new AI voice tool promises consistency for DSOs, but in a crowded market, will its integrated approach redefine workflows and patient care?

A new FDA-approved device offers a drug-free alternative for severe rheumatoid arthritis. Rush University is the first in Chicago to implant the system.

Estrella Immunopharma unveils promising Phase 1 data for its next-gen T-cell therapy, but can it overcome a crowded market and its own financial hurdles?

Eli Lilly partners with China's Zonsen PepLib, betting on its novel peptide platforms to fuel the next wave of therapies in oncology and metabolism.

Omilia has launched a self-learning AI platform promising 'zero-day go-live' for autonomous agents, challenging the entire customer service industry.

New Medicare rules expand access to opioid alternatives, reshaping post-surgery recovery and rewarding companies at the forefront of pain management.

As CFO Mike Santomassimo prepares for the UBS conference, investors seek clarity on Wells Fargo's strategy after its asset cap removal and rate cut impacts.

An independent analysis shows a specialized OB/GYN staffing model improves maternal outcomes, lowers C-section rates, and delivers a significant return on investment.

Colonial Heights schools adopt AI gun detection to boost safety, but the tech faces scrutiny over its real-world effectiveness and privacy implications.

Novo Nordisk exec Karin Conde-Knape joins Valo as CSO, signaling a major validation for AI's role in creating next-generation medicines.

Arbor Realty Trust earned a key Fitch upgrade for its special servicer capabilities, citing tech and expertise, even as market watchers focus on credit quality.

As X4 Pharmaceuticals preps for a key investor summit, all eyes are on its pivotal trial for chronic neutropenia and the commercial fate of XOLREMDI®.

The convenience store giant released preliminary 2025 financials as its subsidiary, ARKO Petroleum Corp., launches a high-stakes IPO roadshow.

Promega's new diagnostic for KEYTRUDA gains NMPA approval, opening doors for targeted solid tumor therapy amid China's growing precision medicine market.

At a critical juncture, Abcourt Mines brings a long-time consultant in-house, betting his expertise can overcome financial hurdles and unlock project value.

A New Mexico health system is betting on a full-scale AI rollout to reduce doctor burnout, improve patient care, and boost its bottom line.

A new report reveals a major shift in hospital spending, with tech and infrastructure costs now rising faster than drugs for the first time in a decade.

After a brutal winter storm cut Bitcoin production, Cango Inc. is selling its crypto reserves to fund a strategic expansion into the booming AI market.